EUVIMEDEUVIMED entdecken
Crossref

Recombinant fibroblast growth factor 4 ameliorates axonal regeneration and functional recovery in acute spinal cord injury through altering microglia/macrophage phenotype

Rui Li, Juerong Feng, Liuxun Li, Guotian Luo, Yongpeng Shi, Shichao Shen, Xinrong Yuan, Jianlong Wu, Bin Yan, Lei Yang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Rui Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedics/Department of Spine Surgery, Department of Pharmacy and Department of Gastroenterology, Shenzhen Second People's Hospital (Shenzhen Inst…. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Microglia, Macrophages, Nerve Regeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation is one of the extensive secondary injury processes that aggravate metabolic and cellular dysfunction and tissue loss following spinal cord injury (SCI). Thus, an anti-inflammatory strategy is crucial for modulating structural and functional restoration during the stage of acute and chronic SCI. Recombinant fibroblast growth factor 4 (rFGF4) has eliminated its mitogenic activity and demonstrated a metabolic regulator for alleviating hyperglycemia in type 2 diabetes and liver injury in non-alcoholic steatohepatitis. However, it remains to be explored whether or not rFGF4 has a neuroprotective effect for restoring neurological disorders, such as SCI. Here, we identified that rFGF4 could polarize microglia/macrophages into the restorative M2 subtype, thus exerting an anti-inflammatory effect to promote neurological functional recovery and nerve fiber regeneration after SCI. Importantly, these effects by rFGF4 were related to triggering PI3K/AKT/GSK3β and attenuating TLR4/NF-κB signaling axes. Conversely, gene silencing of the PI3K/AKT/GSK3β signaling or pharmacological reactivation of the TLR4/NF-κB axis aggravated inflammatory reaction. Thus, our findings highlight rFGF4 as a potentially therapeutic regulator for repairing SCI, and its outstanding effect is associated with regulating macrophage/microglial polarization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Cord InjuriesMicrogliaMacrophagesNerve RegenerationRecovery of FunctionGlycogen Synthase Kinase 3 betaNF-kappa BAnimalsRecombinant ProteinsSignal TransductionToll-Like Receptor 4Phosphatidylinositol 3-KinasesMiceMaleAxonsProto-Oncogene Proteins c-aktMice, Inbred C57BLRats, Sprague-DawleyNeuroprotective AgentsPhenotypeRatsHumansDisease Models, AnimalAnti-Inflammatory Agents

Stichwörter der Autor:innen

Microglia/macrophage polarizationNeuroinflammationNeuroprotectionRecombinant fibroblast growth factor 4 (rFGF4)Spinal cord injury (SCI)

Substanzen

Glycogen Synthase Kinase 3 betaNF-kappa BRecombinant ProteinsToll-Like Receptor 4Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktNeuroprotective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Orthopaedics/Department of Spine Surgery, Department of Pharmacy and Department of Gastroenterology, Shenzhen Second People's Hospital (Shenzhen Institute of Translational Medicine), Guangdong Key Laboratory for Biomedi…

Zitieren

APA

Li, R., Feng, J., Li, L., Luo, G., Shi, Y., Shen, S., Yuan, X., Wu, J., Yan, B., & Yang, L. (2024). Recombinant fibroblast growth factor 4 ameliorates axonal regeneration and functional recovery in acute spinal cord injury through altering microglia/macrophage phenotype. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112188

Vancouver

Li R, Feng J, Li L, Luo G, Shi Y, Shen S, et al. Recombinant fibroblast growth factor 4 ameliorates axonal regeneration and functional recovery in acute spinal cord injury through altering microglia/macrophage phenotype. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112188

BibTeX
@article{Li2024,
  author = {Li, Rui and Feng, Juerong and Li, Liuxun and Luo, Guotian and Shi, Yongpeng and Shen, Shichao and Yuan, Xinrong and Wu, Jianlong and Yan, Bin and Yang, Lei},
  title = {Recombinant fibroblast growth factor 4 ameliorates axonal regeneration and functional recovery in acute spinal cord injury through altering microglia/macrophage phenotype},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112188}
}
Kostenlos starten →